N-acetyl cysteine treatment reduces mercury-induced neurotoxicity in the developing rat hippocampus

Journal of Neuroscience Research

Volumn 90, Issue 4, 2012, Pages 743-750

  Falluel Morel, Anthony ^a,b   Lin, Lulu ^a   Sokolowski, Katie ^a   Mccandlish, Elizabeth ^c,d   Buckley, Brian ^c,d   Dicicco Bloom, Emanuel ^a,d,e  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITÉ DE ROUEN   (France)

^c RUTGERS UNIVERSITY   (United States)

^d UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^e ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Hippocampus; Mercury; N acetyl cysteine; Neurogenesis; Programmed cell death

Indexed keywords

ACETYLCYSTEINE; CASPASE 3; METHYLMERCURY;

ANIMAL CELL; ARTICLE; BRAIN DEVELOPMENT; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; FEMALE; HIPPOCAMPUS; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

ACETYLCYSTEINE; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; CELL DEATH; CELLS, CULTURED; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; FEMALE; HIPPOCAMPUS; MALE; METHYLMERCURY COMPOUNDS; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; PREGNANCY; RATS; SPECTROPHOTOMETRY, ATOMIC; THYMIDINE; TRITIUM;

EID: 84856726495     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22819     Document Type: Article

References (30)

1. Adams J, Barone S, LaMantia A, Philen R, Rice DC, Spear L, Susser E. 2000. Workshop to identify critical windows of exposure for children's health: neurobehavioral work group summary. Environ Health Perspect 108: 535-544.
2. Aposhian HV, Morgan DL, Queen HL, Maiorino RM, Aposhian MM. 2003. Vitamin C, glutathione, or lipoic acid did not decrease brain or kidney mercury in rats exposed to mercury vapor. J Toxicol Clin Toxicol 41: 339-347.
3. Aremu DA, Madejczyk MS, Ballatori N. 2008. N-acetylcysteine as a potential antidote and biomonitoring agent of methylmercury exposure. Environ Health Perspect 116: 26-31.
4. Ballatori N, Lieberman NW, Wang W. 1998. N-acetylcysteine as an antidote in methylmercury poisoning. Environm Health Perspect 106: 267-271.
5. Buist SC, Cherrington NJ, Choudhuri S, Hartley DP, Klaassen CD. 2002. Gender-specific and developmental influences on the expression of rat organic anion transporters. J Pharmacol Exp Ther 301: 145-151.
6. Burke K, Cheng Y, Li B, Petrov A, Joshi P, Berman RF, Reuhl KR, DiCicco-Bloom E. 2006. Methylmercury elicits rapid inhibition of cell proliferation in the developing brain and decreases cell cycle regulator, cyclin E. Neurotoxicology 27: 970-981.
7. Burbacher TM, Shen DD, Liberato N, Grant KS, Cernichiari E, Clarkson T. 2005. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ Health Pespect 113: 1015-1021.
8. Carey RG, Li B, DiCicco-Bloom E. 2002. Pituitary adenylate cyclase activating polypeptide anti-mitogenic signaling in cerebral cortical progenitors is regulated by p57Kip2-dependant CDK2 activity. J Neurosci 22: 1583-1591.
9. Chang LW, Reuhl KR, Lee GW. 1977. Degenerative changes in the developing nervous system as a result of in utero exposure to methylmercury. Environ Res 14: 414-423.
10. Cheng Y, Black IB, DiCicco-Bloom E. 2002. Hippocampal granule neuron production and population size are regulated by levels of bFGF. Eur J Neurosci 15: 3-12.
11. Clarkson TW, Vyas JB, Ballatori N. 2007. Mechanisms of mercury disposition in the body. Am J Indust Med 50: 757-764.
12. Dringen R, Hamprecht B. 1999. N-acetylcysteine, but not methionine or 2-oxothiazolidine-4-carboxylate, serves as cysteine donor for the synthesis of glutathione in cultured neurons derived from embryonal rat brain. Neurosci Lett 259: 79-82.
13. Falluel-Morel A, Sokolowski K, Sisti HM, Zhou X, Shors TJ, Dicicco-Bloom E. 2007. Developmental mercury exposure elicits acute hippocampal cell death, reductions in neurogenesis, and severe learning deficits during puberty. J Neurochem 103: 1968-1981.
14. Haase H, Engelhardt G, Hebel S, Rink L. 2011. Mercuric ions inhibit mitogen-activated protein kinase dephosphorylation by inducing reactive oxygen species. Toxicol Appl Pharmacol 250: 78-86.
15. 2 chemosensitivity. Blood 99: 1552-1555.
16. Kaur P, Aschner M, Syversen T. 2007. Role of glutathione in determining the differential sensitivity between the cortical and cerebellar regions towards mercury-induced oxidative stress. Toxicology 230: 164-177.
17. Koh AS, Simmons-Willis TA, Pritchard JB, Grassl SM, Ballatori N. 2002. Identification of a mechanism by which the methylmercury antidotes N-acetylcysteine and dimercaptopropanesulfonate enhance urinary metal excretion: transport by the renal organic anion transporter-1. Mol Pharmacol 62: 921-926.
18. Lapham LW, Cernichiari E, Cox C, Myers GJ, Baggs RB, Brewer R, Shamlaye CF, Davidson PW, Clarkson TW. 1995. An analysis of autopsy brain tissue from infants prenatally exposed to methymercury. Neurotoxicology 16: 689-704.
19. Lu N, DiCicco-Bloom E. 1997. Pituitary adenylate cyclase-activating polypeptide is an autocrine inhibitor of mitosis in cultured cortical precursor cells. Proc Natl Acad Sci U S A 94: 3357-3362.
20. Madejczyk MS, Aremu DA, Simmons-Willis TA, Clarkson TW, Ballatori N. 2007. Accelerated urinary excretion of methylmercury following administration of its antidote N-acetylcysteine requires Mrp2/Abcc2, the apical multidrug resistance-associated protein. J Pharmacol and Exp Ther 322: 378-384.
21. Newland MC, Reile PA, Langston JL. 2004. Gestational exposure to methylmercury retards choice in transition in aging rats. Neurotoxicol Teratol 26: 179-194.
22. Palmer LA, Doctor A, Chhabra P, Sheram ML, Laubach VE, Karlinsey MZ, Forbes MS, Macdonald T, Gaston B. 2007. S-nitrosothiols signal hypoxia-mimetic vascular pathology. J Clin Invest 117: 2592-2601.
23. Rooney JP. 2007. The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury. Toxicology 234: 145-156.
24. Shimizu E, Hashimoto K, Komatsu N, Iyo M. 2002. Roles of endogenous glutathione levels on 6-hydroxydopamine-induced apoptotic neuronal cell death in human neuroblastoma SK-N-SH cells. Neuropharmacology 43: 434-443.
25. Sokolowski K, Falluel-Morel A, Zhou X, DiCicco-Bloom E. 2011. Methylmercury (MeHg) elicits mitochondrial-dependent apoptosis in developing hippocampus and acts at low exposures. Neurotoxicology (in press).
26. Spurgeon A. 2006. Prenatal methylmercury exposure and developmental outcomes: review of the evidence and discussion of future directions. Environ Health Perspect 114: 307-312.
27. Stein J, Schettler T, Wallinga D, Valenti M. 2002. In harm's way: toxic threats to child development. J Dev Behav Pediatr 23: S13-S22.
28. Wagner JP, Black IB, DiCicco-Bloom E. 1999. Stimulation of neonatal and adult brain neurogenesis by subcutaneous injection of basic fibroblast growth factor. J Neurosci 19: 6006-6016.
29. Zalups RK, Ahmad S. 2005. Transport of N-acetylcysteine s-conjugates of methylmercury in Madin-Darby canine kidney cells stably transfected with human isoform of organic anion transporter 1. J Pharmacol Exp Ther 314: 1158-1168.
30. Zieminska E, Toczylowska B, Stafiej A, Lazarewick JW. 2010. Low molecular weight thiols reduce thimerosal neurotoxicity in vitro: modulation by proteins. Toxicology 276: 154-163.